Lethal obesity associated with sodium valproate in a brain-injured patient

被引:1
作者
Black, DN
Althoff, RR
Daye, K
Pelletier, CA
机构
[1] Vermont State Hosp, Waterbury, VT 05671 USA
[2] Univ Vermont, Dept Neurol, Burlington, VT USA
[3] Univ Vermont, Dept Psychiat, Burlington, VT USA
关键词
appetite; orbitofrontal; valproate;
D O I
10.1097/01.wnn.0000152204.71409.2e
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
A 34-year-old man developed posttraumatic epilepsy and a disinhibited orbitofrontal syndrome following severe head trauma at age 22. After an 11-year prison term marked by repeated impulsive aggression, he was transferred to a state psychiatric hospital. Replacement of phenytoin by valproic acid resulted in a 100-lb weight gain, exacerbation of sleep apnea, and right heart failure. Despite replacement of valproate with topiramate, he died of a cardiorespiratory arrest during a seizure. This case illustrates the potential risks associated with valproate therapy in the obese brain-damaged population.
引用
收藏
页码:98 / 101
页数:4
相关论文
共 37 条
[1]   THE PHENOMENOLOGY OF THE HUMAN KLUVER-BUCY SYNDROME [J].
AICHNER, F .
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 1984, 52 (11) :375-397
[2]   The amygdala and reward [J].
Baxter, MG ;
Murray, EA .
NATURE REVIEWS NEUROSCIENCE, 2002, 3 (07) :563-573
[3]   INSENSITIVITY TO FUTURE CONSEQUENCES FOLLOWING DAMAGE TO HUMAN PREFRONTAL CORTEX [J].
BECHARA, A ;
DAMASIO, AR ;
DAMASIO, H ;
ANDERSON, SW .
COGNITION, 1994, 50 (1-3) :7-15
[4]  
Benton A., 1974, The revised visual retention test
[5]   Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy [J].
Biton, V ;
Mirza, W ;
Montouris, G ;
Vuong, A ;
Hammer, AE ;
Barrett, PS .
NEUROLOGY, 2001, 56 (02) :172-177
[6]  
Bridle C, 2004, HEALTH TECHNOL ASSES, V8, P1
[7]   Weight gain in epileptic patients during treatment with valproic acid: a retrospective study [J].
Corman, CL ;
Leung, NM ;
Guberman, AH .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1997, 24 (03) :240-244
[8]   VALPROIC ACID - A REAPPRAISAL OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL EFFICACY IN EPILEPSY [J].
DAVIS, R ;
PETERS, DH ;
MCTAVISH, D .
DRUGS, 1994, 47 (02) :332-372
[9]   Weight gain associated with valproate in childhood [J].
Demir, E ;
Aysun, S .
PEDIATRIC NEUROLOGY, 2000, 22 (05) :361-364
[10]   EFFECTS OF SODIUM VALPROATE IN 100 CHILDREN WITH SPECIAL REFERENCE TO WEIGHT [J].
EGGER, J ;
BRETT, EM .
BMJ-BRITISH MEDICAL JOURNAL, 1981, 283 (6291) :577-581